Anti-Beta Interferon (PF-06823859)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
50	皮膚筋炎／多発性筋炎	1

50. 皮膚筋炎／多発性筋炎

臨床試験数 : 194 / 薬物数 : 244 - (DrugBank : 89) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 151

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05192200 (ClinicalTrials.gov)	December 20, 2021	1/12/2021	An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent S ...	AN OPEN LABEL, LONG-TERM EXTENSION STUDY TO INVESTIGATE THE SAFETY OF PF-06823859 ADMINISTERED TO AD ...	Dermatomyositis	Drug: Anti-Beta Interferon (PF-06823859)	Pfizer	NULL	Active, not recruiting	18 Years	80 Years	All	24	Phase 2	United States;Hungary;Poland;Spain

First Previous1Next Last